1,541
Views
24
CrossRef citations to date
0
Altmetric
Research Article

Targeted delivery of etoposide to cancer cells by folate-modified nanostructured lipid drug delivery system

, , , &
Pages 1838-1845 | Received 11 Dec 2015, Accepted 08 Jan 2016, Published online: 16 Feb 2016

References

  • Beg S, Sandhu PS, Batra RS, et al (2015). QbD-based systematic development of novel optimized solid self-nanoemulsifying drug delivery systems (SNEDDS) of lovastatin with enhanced biopharmaceutical performance. Drug Deliv 22:765–84.
  • Dai W, Fan Y, Zhang H, et al (2015). A comprehensive study of iRGD-modified liposomes with improved chemotherapeutic efficacy on B16 melanoma. Drug Deliv 22:10–20.
  • Feng R, Zhang Z, Li Z, et al (2014). Preparation and in vitro evaluation of etoposide-loaded PLGA microspheres for pulmonary drug delivery. Drug Deliv 21:185–92.
  • Grinberg S, Linder C, Heldman E. (2014). Progress in lipid-based nanoparticles for cancer therapy. Crit Rev Oncog 19:247–60.
  • Ji H, Tang J, Li M, et al (2015). Curcumin-loaded solid lipid nanoparticles with Brij78 and TPGS improved in vivo oral bioavailability and in situ intestinal absorption of curcumin. Drug Deliv 2015
  • Jiang H, Pei L, Liu N, et al (2015). Etoposide-loaded nanostructured lipid carriers for gastric cancer therapy. Drug Deliv 2015
  • Kılıçay E, Demirbilek M, Türk M, et al (2011). Preparation and characterization of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBHHX) based nanoparticles for targeted cancer therapy. Eur J Pharm Sci 44:310–20.
  • Kuo YC, Hong TY. (2014). Delivering etoposide to the brain using catanionic solid lipid nanoparticles with surface 5-HT-moduline. Int J Pharm 465:132–42.
  • Kuo YC, Lee CH. (2015). Inhibition against growth of glioblastoma multiforme in vitro using etoposide-loaded solid lipid nanoparticles with p-aminophenyl-α-D-manno-pyranoside and folic acid. J Pharm Sci 104:1804–14.
  • Liu X, Zhang Z, Jiang Y, et al (2015). Novel PEG-grafted nanostructured lipid carrier for systematic delivery of a poorly soluble anti-leukemia agent Tamibarotene: characterization and evaluation. Drug Deliv 22:223–9.
  • Mishra BJ, Kaul A, Trivedi P. (2015). L-Cysteine conjugated poly L-lactide nanoparticles containing 5-fluorouracil: formulation, characterization, release and uptake by tissues in vivo. Drug Deliv 22:214–22.
  • Mutalik S, Shetty PK, Kumar A, et al (2014). Enhancement in deposition and permeation of 5-fluorouracil through human epidermis assisted by peptide dendrimers. Drug Deliv 21:44–54.
  • Singh J, Garg T, Rath G, et al (2015). Advances in nanotechnology-based carrier systems for targeted delivery of bioactive drug molecules with special emphasis on immunotherapy in drug resistant tuberculosis – a critical review. Drug Deliv 1–23.
  • Song Z, Zhu W, Song J, et al (2015). Linear-dendrimer type methoxy-poly (ethylene glycol)-b-poly (ɛ-caprolactone) copolymer micelles for the delivery of curcumin. Drug Deliv 22:58–68.
  • Taghdisi SM, Danesh NM, Sarreshtehdar Emrani A, et al (2013). Targeted delivery of Epirubicin to cancer cells by PEGylated A10 aptamer. J Drug Target 21:739–44.
  • Taratula O, Kuzmov A, Shah M, et al (2013). Nanostructured lipid carriers as multifunctional nanomedicine platform for pulmonary co-delivery of anticancer drugs and siRNA. J Control Release 171:349–57.
  • Tian J, Wang L, Wang L, et al (2014). A wogonin-loaded glycyrrhetinic acid-modified liposome for hepatic targeting with anti-tumor effects. Drug Deliv 21:553–9.
  • Varshosaz J, Hassanzadeh F, Sadeghi-Aliabadi H, et al (2014). Uptake of etoposide in CT-26 cells of colorectal cancer using folate targeted dextran stearate polymeric micelles. Biomed Res Int 2014:708593
  • Wang J, Zhu R, Sun X, et al (2014). Intracellular uptake of etoposide-loaded solid lipid nanoparticles induces an enhancing inhibitory effect on gastric cancer through mitochondria-mediated apoptosis pathway. Int J Nanomedicine 9:3987–98.
  • Wang R, Xiao R, Zeng Z, et al (2012). Application of poly(ethylene glycol)-distearoylphosphatidylethanolamine (PEG-DSPE) block copolymers and their derivatives as nanomaterials in drug delivery. Int J Nanomedicine 7:4185–98.
  • Wang Y, Li P, Chen L, et al (2015). Targeted delivery of 5-fluorouracil to HT-29 cells using high efficient folic acid-conjugated nanoparticles. Drug Deliv 22:191–8.
  • Yan J, Wang Y, Zhang X, et al (2015). Targeted nanomedicine for prostate cancer therapy: docetaxel and curcumin co-encapsulated lipid-polymer hybrid nanoparticles for the enhanced anti-tumor activity in vitro and in vivo. Drug Deliv
  • Yoon IS, Park JH, Kang HJ, et al (2015). Poly(D,L-lactic acid)-glycerol-based nanoparticles for curcumin delivery. Int J Pharm 488:70–7.
  • Yordanov G, Skrobanska R, Evangelatov A. (2013). Colloidal formulations of etoposide based on poly(butyl cyanoacrylate) nanoparticles: preparation, physicochemical properties and cytotoxicity. Colloids Surf B Biointerfaces 101:215–22.
  • Zhang G, Liu F, Jia E, et al (2015a). Folate-modified, cisplatin-loaded lipid carriers for cervical cancer chemotherapy. Drug Deliv. 2015
  • Zhang S, Tang C, Yin C. (2015b). Effects of poly(ethylene glycol) grafting density on the tumor targeting efficacy of nanoparticles with ligand modification. Drug Deliv 22:182–90.
  • Zhang T, Chen J, Zhang Y, et al (2011). Characterization and evaluation of nanostructured lipid carrier as a vehicle for oral delivery of etoposide. Eur J Pharm Sci 43:174–9.
  • Zhang Z, Yao J. (2012). Preparation of irinotecan-loaded folate-targeted liposome for tumor targeting delivery and its antitumor activity. AAPS PharmSciTech 13:802–10.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.